Jonathan Heller
Nessuna posizione attualmente
Profilo
Jonathan Heller was the founder of Teton Therapeutics, Inc. which was founded in 2017, where he held the title of Chief Executive Officer from 2017 to 2019.
He also held the position of Director-Early Stage Programs at BioMarin Pharmaceutical, Inc. from 2013 to 2015.
Additionally, he held the title of Vice President-Research Operations at Erimos Pharmaceuticals LLC and Chief Science Officer, Head-Research & Development at Ocean Biomedical, Inc. (United States).
Dr. Heller received his undergraduate degree from The Reed Institute, his MBA from the University of California, Berkeley, and his doctorate from John Hopkins University Atlantic Basin Policy Institute.
Precedenti posizioni note di Jonathan Heller
| Società | Posizione | Fine |
|---|---|---|
Teton Therapeutics, Inc.
 Teton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Teton Therapeutics, Inc. develops novel therapies for neurofibromatosis. The private company is based in Belmont, MA. The company was founded by Jonathan Heller. | Amministratore Delegato | 01/01/2019 |
| BIOMARIN PHARMACEUTICAL INC. | Corporate Officer/Principal | 01/01/2015 |
Erimos Pharmaceuticals LLC
 Erimos Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Erimos Pharmaceuticals LLC manufactures drugs. It is a biopharmaceutical company focused primarily on the discovery, development and commercialization of small molecule drugs to prevent and treat cancer. The firm’s pre-clinical programs are underway to create advancements in treating other serious medical conditions including influenza, Alzheimer’s disease, diabetes, psoriasis, obesity, and infectious disease. The company was founded by Franklin C. Jesse Jr. and Jeffrey Khoo in 2000 and is headquartered in Houston, TX. | Corporate Officer/Principal | - |
Ocean Biomedical, Inc. (United States)
 Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Jonathan Heller
| The Reed Institute | Undergraduate Degree |
| University of California, Berkeley | Masters Business Admin |
| John Hopkins University Atlantic Basin Policy Institute | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| BIOMARIN PHARMACEUTICAL INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Erimos Pharmaceuticals LLC
Erimos Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Erimos Pharmaceuticals LLC manufactures drugs. It is a biopharmaceutical company focused primarily on the discovery, development and commercialization of small molecule drugs to prevent and treat cancer. The firm’s pre-clinical programs are underway to create advancements in treating other serious medical conditions including influenza, Alzheimer’s disease, diabetes, psoriasis, obesity, and infectious disease. The company was founded by Franklin C. Jesse Jr. and Jeffrey Khoo in 2000 and is headquartered in Houston, TX. | Health Technology |
Teton Therapeutics, Inc.
Teton Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Teton Therapeutics, Inc. develops novel therapies for neurofibromatosis. The private company is based in Belmont, MA. The company was founded by Jonathan Heller. | Health Technology |
Ocean Biomedical, Inc. (United States)
Ocean Biomedical, Inc. (United States) Miscellaneous Commercial ServicesCommercial Services Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria, Jonathan Kurtis and Jack A. Elias on January 2, 20219 and is headquartered in Providence, RI. | Commercial Services |
- Borsa valori
- Insiders
- Jonathan Heller